All Q1 FY27 results →
U

UPL

Q1 FY27Fertilizers & Agrochemicals

UPL Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹553
Market cap₹48.9K Cr
P/E24.8
Updated23 Sept 2026
Read4 min read

What the Q1 FY27 call signalled

2 of 5 strong

RevenueSlow growth
MarginMargins steady
CapexCapex planned
FundraiseNo fundraise planned
Order bookOrder book rising

The short version

UPL expects full-year revenue growth of 7% to 11% for FY27. UPL expects full-year revenue growth of 7% to 11% and EBITDA growth of 10% to 14% for FY27.

From UPL's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.

Revenue & Sales Performance

Slow growth
  • UPL expects full-year revenue growth of 7% to 11% for FY27.
  • Volume growth is anticipated especially in the seeds and super specialty businesses, with super specialty showing sustained multi-year growth.
  • Global Crop Protection (CP) volume growth is expected to improve during the year, supported by market share gains and cautious channel inventory management.
  • India CP business expects strong performance due to hyperscale brands, innovation, and improved product mix.
  • Latam volumes are expected to be strong from Q2 onwards, particularly in Brazil with the upcoming planting season.
  • Pricing is proactive with increases incorporated to offset cost inflation, with no expected price decline.

2 more points from UPL's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what UPL said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • In Q1 FY27, UPL made capital investments amounting to ₹669 crores, primarily related to their associate Sinova in Brazil (Page 15).
  • The company has planned additional capex and strategic investments, which contributed to net debt being flat year-on-year in U.S. dollar terms despite debt reduction (Page 5).
  • UPL also mentioned investment in specialty platforms that support growth in super specialty and ag segments (Page 14).
  • Overall, UPL emphasizes disciplined capital management and sustaining investments aligned with long-term value creation (Pages 5 & 8).

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what UPL said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Order book rising
  • For the upcoming planting season in Brazil, the channel is starting to load, finalizing harvest of the second corn season, with planting beginning in September-October for the new soybean crop.
  • The company is well-positioned with a strong order book.
  • Customers have been cautious in loading inventory, buying just in time due to geopolitical conflicts and pricing uncertainties.
  • The order book and channel positioning give UPL confidence for strong volume growth in Q2, Q3, and Q4.

2 more points from UPL's call on order book

Create a free account to keep reading this call

UPL — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹18.3K Cr, net profit ₹1.3K Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Rama Phosphates Ltd (Q1 FY27)

    Q1 FY27 Revenue from Operations: ₹22,480 Lacs, up 18% YoY from ₹19,031 Lacs in Q1 FY26. Key investor presentation takeaways from Rama Phosphates's Q1 FY27 inves

  • Advance Agrolife Ltd (Q1 FY27)

    Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key concall takeaways from Advance Agrolife Ltd's Q1 FY27…

  • Bhagiradha Chemicals & Industries Ltd (Q1 FY27)

    195.0 crore . Key concall takeaways from Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

  • Sumitomo Chemical India Ltd (Q1 FY27)

    1,063.3 crore, a 1% year-on-year (YoY) increase from Rs. Key concall takeaways from Sumitomo Chemical India Ltd's Q1 FY27 earnings call — and how it ranks…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

UPL and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were UPL Q1 FY27 results?

UPL expects full-year revenue growth of 7% to 11% for FY27. UPL expects full-year revenue growth of 7% to 11% and EBITDA growth of 10% to 14% for FY27.

What is UPL share price analysis?

UPL currently shows a neutral. The stock trades at a P/E of 24.8 with a market cap of ₹48,946 Cr. Investors should review the full earnings analysis for detailed insights.

Is UPL planning capital expenditure?

In Q1 FY27, UPL made capital investments amounting to ₹669 crores, primarily related to their associate Sinova in Brazil (Page 15). - The company has planned additional capex and strategic investments, which contributed to net debt being flat year-on-year in U.S.

Keep UPL on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.